Close
American Drug Delivery & Formulation Summit
Xylem

Progenra deploys Dotmatics drug research platform

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Digital Health Tools Are Transforming Patient Care Models

The integration of advanced technology into the clinical environment...

Quantum Computing Advancing Molecular Discovery Models

Harnessing the power of subatomic physics to simulate complex biological interactions at an atomic level, unlocking new frontiers in drug discovery and precision medicine through unprecedented computational speed.
- Advertisement -

Progenra, a biotechnology company, has selected Dotmatics’ suite of scientific informatics solutions to enhance its drug research and development process.

The Dotmatics platform is a fully optimized suite of programs designed to make research data readily accessible and useful.

The company’s suite of solutions are used to manage and analyze the critical scientific data which allows users to integrate and view complex research data from disparate sources.

Progenra Business Development senior director Marc Hixson said, “Having evaluated other solutions, Progenra replaced legacy CambridgeSoft tools with the Dotmatics platform because of the seamless interface and ease of use which has allowed Progenra to effectively and efficiently manage their internal and external programs.”

Dotmatics is a scientific software company deploying web-based knowledge solutions that dramatically improve the way scientific data is queried, managed and shared within companies.

World Pharma Today brings together the global pharmaceutical industry โ€” from R&D leaders and regulatory affairs professionals to manufacturers and distribution executives โ€” through trusted editorial, market intelligence, and digital engagement.

Our 2026 Media Pack offers integrated solutions to reach your audience:

  • Magazine & Digital Editions Showcase your brand within premium pharmaceutical industry coverage read by executives and decision - makers worldwide.
  • Industry Insights & Reports Align with data - driven analysis, trend reports, and regional roundups across the global pharmaceutical and life sciences value chain.
  • Brand Authority & Credibility Position your company as a thought leader through expert commentary, interviews, and special features.

Latest stories

Related stories

Digital Health Tools Are Transforming Patient Care Models

The integration of advanced technology into the clinical environment...

Quantum Computing Advancing Molecular Discovery Models

Harnessing the power of subatomic physics to simulate complex biological interactions at an atomic level, unlocking new frontiers in drug discovery and precision medicine through unprecedented computational speed.

Digital Therapeutics Expanding Pharmaceutical Care

Redefining patient treatment through clinically validated software interventions that complement or replace traditional medications, offering personalized, remote, and scalable care for chronic conditions.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป